4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001615774-18-000382
Chief Executive Officer disposed of 171,832 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silvers Daniel B. Chief Executive Officer | 2018-01-15 | Other disposition | −171,832 | 1,128,370 | I |
Loading xslF345X03/s108737_form4.xml…